Skip to main content
Shedir Pharma Group logo

Shedir Pharma Group — Investor Relations & Filings

Ticker · SHE ISIN · IT0005379620 LEI · 81560092B300849E9017 XMIL Manufacturing
Open in API
Filings indexed 124 across all filing types
Latest filing 2025-01-23 Delisting Announcement
Country IT Italy
Listing XMIL SHE

About Shedir Pharma Group

https://www.shedirpharmagroup.com

Shedir Pharma Group specializes in the research, development, formulation, and commercialization of health and wellness products. The company's portfolio encompasses nutraceuticals, dermocosmetics, medical devices, and pharmaceuticals. A key focus is on innovation, resulting in the creation of unique and patented product formulations that cover approximately 15 therapeutic areas. The group operates through specialized subsidiaries that manage the entire product lifecycle, from initial research and intellectual property to marketing and distribution. Products are offered in various forms, such as capsules, tablets, powders, liquids, and gels, targeting professionals in the medical and pharmaceutical sectors.

Recent filings

Filing Released Lang Actions
COMUNICAZIONE AVENTE AD OGGETTO OFFERTA PUBBLICA DI ACQUISTO VOLONTARIA TOTALITARIA
Delisting Announcement Classification · 99% confidence The document is an official communication from SHEDIR PHARMA GROUP S.P.A. regarding the completion of a voluntary takeover bid (Offerta Pubblica di Acquisto Volontaria Totalitaria) by Dimainvest S.r.l. The key subject is the execution of the squeeze-out procedure (Procedura Congiunta ai sensi dell'art. 111 del TUF) and the subsequent delisting of the shares from Euronext Growth Milan, effective immediately ('a decorrere dalla data odierna'). This announcement details the final steps of a takeover process, which directly relates to capital structure changes and the removal of the stock from the exchange. Since the document explicitly announces the delisting ('DELISTING DELLE AZIONI SHEDIR PHARMA GROUP S.P.A. A DECORRERE DALLA DATA ODIERNA'), the most specific category is Delisting Announcement (DLST). While it relates to a takeover (TAR), the primary action being communicated here is the final consequence: the delisting.
2025-01-23 Italian
COMUNICAZIONE AVENTE AD OGGETTO OFFERTA PUBBLICA DI ACQUISTO VOLONTARIA TOTALITARIA
Delisting Announcement Classification · 99% confidence The document is an official communication from SHEDIR PHARMA GROUP regarding the definitive results of a Voluntary Tender Offer (Offerta Pubblica di Acquisto Volontaria Totalitaria) launched by Dimainvest S.r.l. It details the acceptance rate, payment dates, and the subsequent exercise of the Right of Purchase (Diritto di Acquisto) leading to the mandatory delisting of the shares. The key subject is the conclusion of a takeover/acquisition process, which directly relates to M&A activity (Takeover/Acquisition/Merger). The filing type 'TAR' (M&A Activity) is the most appropriate classification for documents detailing the final results and consequences (like delisting) of a tender offer.
2025-01-13 Italian
COMUNICAZIONE AVENTE AD OGGETTO OFFERTA PUBBLICA DI ACQUISTO VOLONTARIA TOTALITARIA
M&A Activity Classification · 99% confidence The document is an official communication from SHEDIR PHARMA GROUP regarding the conclusion of the acceptance period for a 'OFFERTA PUBBLICA DI ACQUISTO VOLONTARIA TOTALITARIA' (Voluntary Total Tender Offer). It details the provisional results of the tender offer, the percentage of shares tendered (10.008%), and the intention to exercise the Right of Purchase (Diritto di Acquisto) to acquire the remaining shares, leading to a potential Delisting. This subject matter—a tender offer, acquisition, and subsequent delisting procedures—falls directly under the scope of M&A Activity (Takeover Bids/Mergers). The appropriate code is TAR.
2025-01-10 Italian
COMUNICAZIONE AVENTE AD OGGETTO OFFERTA PUBBLICA DI ACQUISTO VOLONTARIA TOTALITARIA
M&A Activity Classification · 98% confidence The document is an official communication ('Informazione Regolamentata') from SHEDIR PHARMA GROUP regarding a 'OFFERTA PUBBLICA DI ACQUISTO VOLONTARIA TOTALITARIA' (Voluntary Total Takeover Bid). The subject explicitly states the nature of the event: a takeover offer. This falls under the category of Merger & Acquisition (M&A) activity. The specific code for M&A activity is TAR (Takeover/Merger Activity). Although the text mentions 'Vedi allegato' (See attachment), the core content is the announcement of the fulfillment of a condition for the takeover bid, making it a substantive M&A announcement rather than just a Report Publication Announcement (RPA).
2025-01-09 Italian
COMUNICAZIONE AVENTE AD OGGETTO OFFERTA PUBBLICA DI ACQUISTO VOLONTARIA TOTALITARIA
M&A Activity Classification · 99% confidence The document is an official communication ('Informazione Regolamentata') from SHEDIR PHARMA GROUP S.P.A. regarding a 'OFFERTA PUBBLICA DI ACQUISTO VOLONTARIA TOTALITARIA' (Voluntary Total Takeover Bid). The key subject is the announcement that the offeror has reached the threshold of 90% of the share capital, which triggers mandatory buy-out obligations and subsequent delisting. This subject matter—a takeover bid and related capital structure changes—most closely aligns with the 'M&A Activity' category (TAR). Although it involves share transactions, the core event is the takeover bid itself, not just a routine repurchase (POS) or a general capital change (SHA). Since the document is a formal announcement detailing the status of a takeover bid, TAR is the most appropriate classification.
2025-01-07 Italian
COMUNICAZIONE AVENTE AD OGGETTO OFFERTA PUBBLICA DI ACQUISTO VOLONTARIA TOTALITARIA
Regulatory Filings Classification · 99% confidence The document is an official communication ('Informazione Regolamentata') from SHEDIR PHARMA GROUP detailing the results of the fifth week of a Voluntary Total Takeover Bid ('OFFERTA PUBBLICA DI ACQUISTO VOLONTARIA TOTALITARIA') promoted by Dimainvest S.r.l. It provides specific data on the number of shares tendered during the period and cumulatively. This type of announcement, which reports on the progress of a takeover bid, falls under the category of Merger & Acquisition (M&A) activity. The specific code for M&A Activity is TAR (Takeover/Acquisition Report). Although it is a progress update, the core subject is the takeover bid itself, making TAR the most appropriate classification over a general regulatory filing (RNS). The document is substantial and contains detailed figures, not just a brief announcement of an attached report.
2025-01-03 Italian

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.